WallStSmart
UTI

Universal Technical Institute Inc

NYSE: UTI · CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES

$36.75
-2.96% today

Updated 2026-06-05

Market cap
$2.06B
P/E ratio
49.22
P/S ratio
2.37x
EPS (TTM)
$0.76
Dividend yield
52W range
$21 – $42
Volume
1.0M

Universal Technical Institute Inc (UTI) Financial statements

SEC filings — annual and quarterly data.

Profit margin
7.54%
Operating margin
9.99%
ROE
12.56%
ROA
4.39%
Debt/equity
0.93x

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2006$347.07M$27.39M50.09%11.74%7.89%
2007$353.37M$15.56M47.29%6.72%4.40%
2008$343.46M$8.22M45.66%3.11%2.39%
2009$366.63M$11.73M47.23%5.08%3.20%
2010$435.92M$28.83M51.23%10.68%6.61%
2011$451.90M$27.24M50.55%9.98%6.03%
2012$413.55M$9.03M48.74%3.41%2.18%
2013$380.27M$3.81M47.53%1.56%1.00%
2014$378.39M$2.04M47.13%1.67%0.54%
2015$362.67M$-9.15M46.39%-2.54%-2.52%
2016$347.15M$-47.70M44.00%-5.36%-13.74%
2017$324.26M$-8.13M44.17%-0.56%-2.51%
2018$316.96M$-32.68M42.39%-11.13%-10.31%
2019$331.50M$-7.87M46.21%-2.35%-2.37%
2020$300.76M$8.01M48.15%-0.86%2.66%
2021$335.08M$14.58M50.22%4.46%4.35%
2022$418.76M$25.85M50.51%5.34%6.17%
2023$607.41M$12.32M45.69%3.52%2.03%
2024$732.69M$42.00M47.52%8.04%5.73%
2025$835.62M$63.02M49.68%9.99%7.54%

Frequently asked questions

What is Universal Technical Institute Inc's revenue?

Universal Technical Institute Inc's trailing twelve-month revenue is $868.99M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is UTI?

In its most recent fiscal year, UTI ran a gross margin of 49.68%, an operating margin of 9.99%, and a net margin of 7.54%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does UTI generate?

UTI produced $55.35M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is UTI's balance sheet healthy?

UTI holds $127.36M in cash and equivalents against $84.23M in long-term debt, on $328.11M of shareholder equity. Cash on hand exceeds long-term debt, so the balance sheet adds little financial risk to the thesis.